March 23, 2018 / 6:29 AM / a month ago

BRIEF-Mabion Confirms Final Results Of Clinical Trial Of MabionCD20 RZS

March 23 (Reuters) - Mabion Sa:

* CONFIRMS THAT POSITIVE PRELIMINARY RESULTS OF CLINICAL TRIAL OF MABIONCD20 RZS CHANGE ITS STATUS TO FINAL

* SAYS POSITIVE RESULTS DO NOT GUARANTEE APPROVAL OF PRODUCT BY EUROPEAN MEDICINES AGENCY (EMA) Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below